Angiotensin II and the ERK Pathway Mediate the Induction of Myocardin by Hypoxia in Cultured Rat Neonatal Cardiomyocytes

Overview

Journal Clin Sci (Lond)

Specialties Biochemistry
General Medicine
Science

Date 2010 May 8

PMID 20446923

Citations 14

Authors

Chiung-Zuan Chiu

Bao-Wei Wang

Tun-Hui Chung

Kou-Gi Shyu

Affiliations

Soon will be listed here.

Abstract

Hypoxic injury to cardiomyocytes is a stress that causes cardiac pathology through cardiac-restricted gene expression. SRF (serum-response factor) and myocardin are important for cardiomyocyte growth and differentiation in response to myocardial injuries. Previous studies have indicated that AngII (angiotensin II) stimulates both myocardin expression and cardiomyocyte hypertrophy. In the present study, we evaluated the expression of myocardin and AngII after hypoxia in regulating gene transcription in neonatal cardiomyocytes. Cultured rat neonatal cardiomyocytes were subjected to hypoxia, and the expression of myocardin and AngII were evaluated. Different signal transduction pathway inhibitors were used to identify the pathway(s) responsible for myocardin expression. An EMSA (electrophoretic mobility-shift assay) was used to identify myocardin/SRF binding, and a luciferase assay was used to identify transcriptional activity of myocardin/SRF in neonatal cardiomyocytes. Both myocardin and AngII expression increased after hypoxia, with AngII appearing at an earlier time point than myocardin. Myocardin expression was stimulated by AngII and ERK (extracellular-signal-regulated kinase) phosphorylation, but was suppressed by an ARB (AngII type 1 receptor blocker), an ERK pathway inhibitor and myocardin siRNA (small interfering RNA). AngII increased both myocardin expression and transcription in neonatal cardiomyocytes. Binding of myocardin/SRF was identified using an EMSA, and a luciferase assay indicated the transcription of myocardin/SRF in neonatal cardiomyocytes. Increased BNP (B-type natriuretic peptide), MHC (myosin heavy chain) and [(3)H]proline incorporation into cardiomyocytes was identified after hypoxia with the presence of myocardin in hypertrophic cardiomyocytes. In conclusion, hypoxia in cardiomyocytes increased myocardin expression, which is mediated by the induction of AngII and the ERK pathway, to cause cardiomyocyte hypertrophy. Myocardial hypertrophy was identified as an increase in transcriptional activities, elevated hypertrophic and cardiomyocyte phenotype markers, and morphological hypertrophic changes in cardiomyocytes.

Citing Articles

Myocardin ablation in a cardiac-renal rat model.

Mittal A, Rana S, Sharma R, Kumar A, Prasad R, Raut S Sci Rep. 2019; 9(1):5872.

PMID: 30971740 PMC: 6458122. DOI: 10.1038/s41598-019-42009-z.

β‑estradiol alleviates hypertension‑ and concanavalin A‑mediated inflammatory responses via modulation of connexins in peripheral blood lymphocytes.

Ni X, Zhang L, Ma X, Shan L, Li L, Si J Mol Med Rep. 2019; 19(5):3743-3755.

PMID: 30896818 PMC: 6471871. DOI: 10.3892/mmr.2019.10037.

Protective effect of HDL on NADPH oxidase-derived super oxide anion mediates hypoxia-induced cardiomyocyte apoptosis.

Wen S, Tamilselvi S, Shen C, Day C, Chun L, Cheng L PLoS One. 2017; 12(6):e0179492.

PMID: 28617849 PMC: 5472312. DOI: 10.1371/journal.pone.0179492.

Dickkopf Homolog 3 Induces Stem Cell Differentiation into Smooth Muscle Lineage via ATF6 Signalling.

Wang X, Karamariti E, Simpson R, Wang W, Xu Q J Biol Chem. 2015; 290(32):19844-52.

PMID: 26105053 PMC: 4528144. DOI: 10.1074/jbc.M115.641415.

STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.

Liao X, Wang N, Zhao D, Zheng D, Zheng L, Xing W J Biol Chem. 2015; 290(32):19641-52.

PMID: 26100622 PMC: 4528129. DOI: 10.1074/jbc.M114.630111.

References

Kontaraki J, Parthenakis F, Patrianakos A, Karalis I, Vardas P . Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy. Cardiovasc Pathol. 2007; 16(6):329-35. DOI: 10.1016/j.carpath.2007.04.004. View

Teg Pipes G, Creemers E, Olson E . The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006; 20(12):1545-56. DOI: 10.1101/gad.1428006. View

Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D . Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circ J. 2006; 70(6):787-92. DOI: 10.1253/circj.70.787. View

Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T . Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol. 2004; 6(6):499-506. DOI: 10.1038/ncb1137. View

Miano J . Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003; 35(6):577-93. DOI: 10.1016/s0022-2828(03)00110-x. View

Hauschka S . Myocardin. a novel potentiator of SRF-mediated transcription in cardiac muscle. Mol Cell. 2001; 8(1):1-2. DOI: 10.1016/s1097-2765(01)00297-0. View

Kontaraki J, Parthenakis F, Patrianakos A, Karalis I, Vardas P . Myocardin gene regulatory variants as surrogate markers of cardiac hypertrophy - study in a genetically homogeneous population. Clin Genet. 2007; 73(1):71-8. DOI: 10.1111/j.1399-0004.2007.00932.x. View

Xing W, Zhang T, Cao D, Wang Z, Antos C, Li S . Myocardin induces cardiomyocyte hypertrophy. Circ Res. 2006; 98(8):1089-97. DOI: 10.1161/01.RES.0000218781.23144.3e. View

Miano J . Channeling to myocardin. Circ Res. 2004; 95(4):340-2. DOI: 10.1161/01.RES.0000140893.16465.2d. View

10.

Baker K, Chernin M, Schreiber T, Sanghi S, Haiderzaidi S, Booz G . Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept. 2004; 120(1-3):5-13. DOI: 10.1016/j.regpep.2004.04.004. View

11.

Yamashita C, Hayashi T, Mori T, Tazawa N, Kwak C, Nakano D . Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice. Hypertens Res. 2008; 30(12):1219-30. DOI: 10.1291/hypres.30.1219. View

12.

Kuwahara K, Barrientos T, Teg Pipes G, Li S, Olson E . Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol. 2005; 25(8):3173-81. PMC: 1069631. DOI: 10.1128/MCB.25.8.3173-3181.2005. View

13.

Hannan R, Luyken J, Rothblum L . Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes. J Biol Chem. 1996; 271(6):3213-20. DOI: 10.1074/jbc.271.6.3213. View

14.

Yamazaki T, Komuro I, Yazaki Y . Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol. 2000; 83(12A):53H-57H. DOI: 10.1016/s0002-9149(99)00259-3. View

15.

Pijnappels D, van Tuyn J, de Vries A, Grauss R, van der Laarse A, Ypey D . Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts. Circulation. 2007; 116(18):2018-28. DOI: 10.1161/CIRCULATIONAHA.107.712935. View

16.

Wang D, Chang P, Wang Z, Sutherland L, Richardson J, Small E . Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105(7):851-62. DOI: 10.1016/s0092-8674(01)00404-4. View

17.

Chang H, Shyu K, Wang B, Kuan P . Regulation of hypoxia-inducible factor-1alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond). 2003; 105(4):447-56. DOI: 10.1042/CS20030088. View

18.

Seta K, Millhorn D . Functional genomics approach to hypoxia signaling. J Appl Physiol (1985). 2004; 96(2):765-73. DOI: 10.1152/japplphysiol.00836.2003. View

19.

van Tuyn J, Pijnappels D, de Vries A, de Vries I, van der Velde-van Dijke I, Knaan-Shanzer S . Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J. 2007; 21(12):3369-79. DOI: 10.1096/fj.07-8211com. View

20.

Firulli A . Another hat for myocardin. J Mol Cell Cardiol. 2002; 34(10):1293-6. DOI: 10.1006/jmcc.2002.2098. View